Icosagen is a research-driven contract research provider for biopharmaceutical and biotechnology industries that deftly adapts to market forces and current trends, and is always guided by the needs of its customers.
The Group is comprised of four entities: parent company Icosagen AS and three subsidiaries: Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ.
- Icosagen AS was established in 1999. Common departments, such as general management, financing/accounting, QC/QA, business development, sales and marketing are represented by the parent company. A portfolio of off-the-shelf products, such as antibodies, proteins, ELISA kits, etc., and quality control services in the field of natural rubber allergen testing and food quality control, are also part of the activities of Icosagen AS.
- Icosagen Cell Factory OÜ was established in 2005. It is a CRO (Contract Research Organization)-type company, developing novel technologies and providing research services to the biopharmaceutical and biotechnology industries and to academia. A portfolio of proprietary technologies (e.g. QMCF Technology for protein production) and custom-tailored services for protein, antibody, VLP. etc., production are offered by Icosagen Cell Factory.
- Icosagen Technologies Inc. was established in 2016, in order to give US customers access to Icosagen's technologies and services.
- IcoPark OÜ was established in 2012, in order to develop the infrastructure of the Icosagen Group.
We are a leading biotechnology group in Estonia having provided custom-tailored services as well as catalogue products for global customers in academia, pharma, biotech and industry for several years.